Notice: This company recently went public with an IPO on Friday, October 25th 2024. They issued 10,937,500 shares at $18.00 per share. We will continue to update data for SEPN as it becomes available. Septerna (SEPN) Competitors $20.02 -0.73 (-3.52%) (As of 10/29/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends SEPN vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDWShould you be buying Septerna stock or one of its competitors? The main competitors of Septerna include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry. Septerna vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Alvotech Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II Biofrontera biote Septerna (NASDAQ:SEPN) and 180 Life Sciences (NASDAQ:ATNFW) are both manufacturing companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, community ranking, dividends, risk, institutional ownership and earnings. Does the media refer more to SEPN or ATNFW? In the previous week, Septerna had 3 more articles in the media than 180 Life Sciences. MarketBeat recorded 4 mentions for Septerna and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.89 beat Septerna's score of 0.50 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Septerna Positive 180 Life Sciences Very Positive Which has preferable valuation and earnings, SEPN or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSepternaN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is SEPN or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets SepternaN/A N/A N/A 180 Life Sciences N/A N/A N/A Do analysts rate SEPN or ATNFW? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Septerna 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A180 Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the MarketBeat Community believe in SEPN or ATNFW? Septerna and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformSepternaN/AN/A180 Life SciencesN/AN/A SummarySepterna and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks. Ad Porter & CompanyUrgent: This election is riggedIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Get Septerna News Delivered to You Automatically Sign up to receive the latest news and ratings for SEPN and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SEPN vs. The Competition Export to ExcelMetricSepternaPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket CapN/A$7.23B$2.17B$8.65BDividend YieldN/A8.78%2.68%4.20%P/E RatioN/A20.5425.0918.82Price / SalesN/A379.67256.3396.49Price / CashN/A49.662.9633.53Price / BookN/A5.901.364.66Net IncomeN/A$149.76M$165.18M$224.69M7 Day PerformanceN/A-0.68%-0.07%0.56%1 Month PerformanceN/A10.53%-0.16%4.00%1 Year PerformanceN/A46.68%17.99%36.39% Septerna Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SEPNSepternaN/A$20.02-3.5%N/AN/A$0.00N/A0.00N/AInsider BuyingNews CoverageATNFW180 Life SciencesN/A$0.01flatN/A+3.6%$0.00N/A0.007Positive NewsGap UpHigh Trading VolumeLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.04-20.0%N/A+61.7%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.05flatN/A-89.5%$0.00$65,122.000.0040News CoverageALVOWAlvotechN/A$3.48+2.1%N/A+78.9%$0.00$306.77M0.004Short Interest ↓Gap UpALVOAlvotech3.2021 of 5 stars$13.08+0.2%$18.00+37.6%+44.7%$0.00$93.38M-4.941,026ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/AN/A$0.00N/A0.004Gap DownACABUAtlantic Coastal Acquisition Corp. IIN/A$11.50flatN/AN/A$0.00N/A0.004Gap DownBFRIWBiofronteraN/A$0.04+30.0%N/A+30.0%$0.00$35.24M0.0070Positive NewsBTMDWbioteN/A$0.60+13.3%N/A+51.9%$0.00$187.23M0.00N/AGap Up Related Companies and Tools Related Companies ATNFW Competitors LBPSW Competitors AEHAW Competitors AIMDW Competitors ALVOW Competitors ALVO Competitors ACABW Competitors ACABU Competitors BFRIW Competitors BTMDW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SEPN) was last updated on 10/29/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Septerna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Septerna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
